This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Estraderm

Novartis AG

Drug Names(s): oestradiol, transdermal estradiol

Description: Estraderm releases estradiol through a rate-limiting membrane continuously upon application to intact skin. Binding of estradiol to estrogen receptors initiates translocation to the nucleus and and changes in gene expression via estrogen response elements.

Estrogens increase the hepatic synthesis of sex hormone binding globulin (SHBG), thyroid-binding globulin (TBG), and other serum proteins and suppress follicle-stimulating hormone (FSH) from the anterior pituitary.


Estraderm News

Pink Sheet Ciba's Vivelle


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug